Document is current
Any future updates will be listed below
-
Authors
Porsdam Mann, Sebastian https://orcid.org/0000-0002-1867-2097
Vazirani, Anuraag A. https://orcid.org/0000-0003-3642-3390
Aboy, Mateo
Earp, Brian D. https://orcid.org/0000-0001-9691-2888
Minssen, Timo https://orcid.org/0000-0002-3286-4888
Cohen, I. Glenn https://orcid.org/0000-0002-0223-3305
Savulescu, Julian
- License Information
-
More Information
Article History
First Online: 13 November 2024
Competing interests
: S.P.M. sits on the ethics advisory boards for AminoChain and Retroviral Therapeutics. I.G.C. is chair of the ethics advisory board for Illumina, a member of the Bayer Bioethics Council, and an advisor for World Class Health. I.G.C. was also compensated for speaking at events organized by Philips with the Washington Post, by the Doctors Company, and for attending the Transformational Therapeutics Leadership Forum organized by Galen Atlantica; he has been retained as an expert in health privacy, gender-affirming care, and reproductive technology lawsuits. T.M. serves as a member of various WHO Committees in Digital Health & Ethics, and as an advisor to Daiki, a company engaged in AI compliance and governance; and as a senior advisor at the law firm X-officio Advokat AB. J.S. is a partner investigator on an Australian Research Council grant LP190100841, which involves industry partnership from Illumina; he does not personally receive any funds from Illumina. J.S. is a bioethics committee consultant for Bayer, and is a bioethics advisor to the Hevolution Foundation. All other authors declare no potential conflicts of interest.
